97 related articles for article (PubMed ID: 19721056)
1. Simultaneous osteonecrosis and osteomyelitis in a patient with cancer of the breast.
Huang KY; Yang RS; Hsieh CC
J Bone Joint Surg Br; 2009 Sep; 91(9):1249-51. PubMed ID: 19721056
[TBL] [Abstract][Full Text] [Related]
2. [A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate].
Tanaka Y; Koga M; Yokomizo Y; Inokuchi S; Koga C; Kusukawa J
Gan To Kagaku Ryoho; 2010 Apr; 37(4):681-5. PubMed ID: 20414026
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of bone associated with combination chemotherapy without corticosteroids.
Marymont JV; Kaufman EE
Clin Orthop Relat Res; 1986 Mar; (204):150-3. PubMed ID: 3006960
[TBL] [Abstract][Full Text] [Related]
4. A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates.
Mouri Y; Yoshida M; Nakano S; Yorozuya K; Fujii K; Fukutomi T; Nakaoka T; Yamada S; Hara K
Breast Cancer; 2009; 16(2):147-50. PubMed ID: 18683023
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
6. Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
Herbozo PJ; Briones DL; Ferres AJ; Torrealba RL
J Oral Maxillofac Surg; 2007 Aug; 65(8):1650-4. PubMed ID: 17656297
[No Abstract] [Full Text] [Related]
7. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
Longo R; Castellana MA; Gasparini G
J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
[No Abstract] [Full Text] [Related]
9. [Osteomyelitis of the jaw in breast cancer patients receiving bisphosphonate therapy].
Tomihara K; Nagai I; Yamaguchi A; Miyazaki A; Dehari H; Abe M; Nakamori K; Komai K; Nakai M; Hiratsuka H
Gan To Kagaku Ryoho; 2008 Jan; 35(1):113-6. PubMed ID: 18195538
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
Shigekawa T; Takeuchi H; Misumi M; Matsuura K; Sano H; Fujiuchi N; Okubo K; Osaki A; Aogi K; Saeki T
Breast Cancer; 2009; 16(1):88-92. PubMed ID: 18478315
[TBL] [Abstract][Full Text] [Related]
11. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
[TBL] [Abstract][Full Text] [Related]
13. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
[TBL] [Abstract][Full Text] [Related]
14. Case 3: infiltrating ductal breast carcinoma.
Peoples GE; Arciero C; Adair C; Shriver CD;
Oncology (Williston Park); 2004 Apr; 18(4):437-8, 440. PubMed ID: 15134352
[No Abstract] [Full Text] [Related]
15. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
Guarneri V; Miles D; Robert N; Diéras V; Glaspy J; Smith I; Thomssen C; Biganzoli L; Taran T; Conte P
Breast Cancer Res Treat; 2010 Jul; 122(1):181-8. PubMed ID: 20361252
[TBL] [Abstract][Full Text] [Related]
16. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
17. Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression.
El-Saify WM
Breast J; 2006; 12(5):490-2. PubMed ID: 16958973
[No Abstract] [Full Text] [Related]
18. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
19. Hand-foot syndrome in breast cancer patients receiving adjuvant chemotherapy.
Lee CK; Lynch J
Intern Med J; 2007 Apr; 37(4):281-2. PubMed ID: 17388876
[No Abstract] [Full Text] [Related]
20. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
Wang ZH; Xu BH
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
